Global Cell Harvesters Market Size By Type (Displacement Collector, Therapy Collector), By Application (Medical Treatment, Science Research), By Region, And Segment Forecasts, 2023 to 2032

lobal Cell Harvesters Market Report Description

The Global Cell Harvesters Market was valued at USD 3.1 billion in 2023 and is projected to reach USD 6.2 billion by 2031, growing at a CAGR of 9.1% during the forecast period from 2023 to 2031. The demand for cell harvesters is accelerating due to advancements in cell-based research, increased adoption of regenerative medicine, and the growing number of biopharmaceutical manufacturing facilities globally. These devices are crucial in separating cells from culture mediums and play a vital role in vaccine production, cell therapy, and diagnostics.

Drivers:

1. Expanding Biopharmaceutical Industry:

The surge in biologics and biosimilars production has necessitated highly efficient cell harvesting processes, leading to a growing demand for technologically advanced harvesters.

2. Growth in Stem Cell and Regenerative Therapies:

With stem cell therapy gaining traction for the treatment of chronic and degenerative diseases, the market is seeing significant investments in harvesting technologies that ensure high yield and viability.

3. Rising Prevalence of Chronic Diseases:

Increasing incidences of cancer, autoimmune, and hematologic disorders are spurring demand for cell therapies and consequently, cell harvesters.

Restraints:

1. High Equipment and Setup Costs:

The acquisition and maintenance costs of sophisticated harvesting equipment can limit market penetration, especially in small-scale labs and emerging economies.

2. Technical Complexity and Skilled Labor Shortage:

Operating and maintaining advanced cell harvesting systems requires skilled professionals, a resource that remains scarce in some regions.

Opportunity:

1. Emerging Markets and Government Support:

Countries in Asia-Pacific and Latin America are expanding their biotech capabilities, with government incentives encouraging infrastructure development and technology acquisition.

2. Automation and Miniaturization Trends:

The push for automated, compact, and high-throughput systems is creating new growth avenues, particularly in personalized medicine and diagnostics.

Market by System Type Insights:

By system type, Continuous Flow Cell Harvesters held the largest share in 2023, attributed to their efficiency in large-scale bioprocessing and consistent cell viability. However, Automated Closed-System Harvesters are expected to register the fastest growth, driven by demand for sterile, contamination-free environments in clinical applications.

Market by End-use Insights:

Based on end-use, the Biopharmaceutical Companies segment dominated the market in 2023. This is due to their extensive use of cell harvesters in vaccine production, therapeutic protein manufacturing, and cell therapy development. Meanwhile, the Academic & Research Institutes segment is anticipated to grow rapidly owing to increasing R&D activities in genomics and cell biology.

Market by Regional Insights:

North America led the global cell harvesters market in 2023, supported by advanced healthcare infrastructure, a strong biopharma industry, and ongoing clinical trials. However, Asia-Pacific is projected to witness the highest growth rate through 2031 due to increasing investment in biotech research, rising patient population, and supportive government initiatives.

Competitive Scenario:

Key players in the global cell harvesters market include Thermo Fisher Scientific Inc., Merck KGaA, Sartorius AG, GE HealthCare, Becton, Dickinson and Company, Lonza Group AG, Miltenyi Biotec, Terumo BCT, and Danaher Corporation. These companies are investing in R&D, expanding manufacturing capacities, and forming strategic alliances to enhance their market position.

Recent Developments:

2023: Sartorius launched a next-gen closed system harvester for GMP-compliant cell therapy manufacturing.

2024: Thermo Fisher partnered with a biotech firm to co-develop a compact, automated cell harvesting platform for clinical settings.

2025: Miltenyi Biotec expanded its production facility in Singapore to cater to the rising demand in the Asia-Pacific region.

Scope of Work – Global Cell Harvesters Market

Report Metric Details

Market Size (2023) USD 3.1 billion

Projected Market Size (2031) USD 6.2 billion

CAGR (2023–2031) 9.1%

Market Segments By System Type (Continuous Flow, Batch, Closed-System), By End-use (Biopharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations), By Region

Growth Drivers Biopharma expansion, Regenerative medicine, Chronic disease prevalence

Opportunities Automation, Emerging markets, Miniaturization of devices

FAQs

1) What is the current market size of the Global